IV cyclophosphamide vs IV dexamethasone and oral cyclophosphamide: Treatment response at 18 months ‐ Sustained remission/steroid sensitive relapses Clinical assessment
IV cyclophosphamide showed no clear difference in treatment response at 18 months: sustained… compared with oral cyclophosphamide plus IV dexamethasone (low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
IV cyclophosphamide vs oral cyclophosphamide plus IV dexamethasone Treatment response at 18 months: sustained remission/steroid‐sensitive relapses · idiopathic steroid‐resistant nephrotic syndrome in children IV cyclophosphamide showed no clear difference in treatment response at 18 months: sustained… compared with oral cyclophosphamide plus IV dexamethasone (low certainty). Interventions for idiopathic steroid‐resistant nephrotic syndrome in children (2019) · Cochrane Headline outcomes only | RR 1.13 [0.65, 1.96] | 1 study · 49 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for idiopathic steroid‐resistant nephrotic syndrome in children 2019 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.